| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8694832 | Burns | 2017 | 9 Pages |
Abstract
Burn patients with adequate renal function and <20% TBSA are candidates for ODA. Tobramycin half-life was similar to healthy, non-burn patients. The larger than normal volume of distribution supports the use of the higher empiric dose of 10Â mg/kg total body or adjusted weight in non-obese and obese patients, respectively, with further dose adjustment based on therapeutic drug monitoring.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Critical Care and Intensive Care Medicine
Authors
Colin Lee, Sandra A.N. Walker, Scott E. Walker, Winnie Seto, Andrew Simor, Marc Jeschke,